Clinical Trials Insight: 700027408

Trial Profile

Clinical Trials Insight: 700027408

Completed
Phase of Trial: Phase I

Latest Information Update: 21 Jul 2011

At a glance

  • Drugs Plovamer (Primary)
  • Indications Multiple sclerosis
  • Focus Adverse reactions; Pharmacodynamics; Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 09 Sep 2009 Results have been presented at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis.
    • 25 Aug 2009 Results will be presented at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, according to a Peptimmune media release.
    • 25 Aug 2009 Status changed from recruiting to completed, as reported in a Peptimmune media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top